The present study served to investigate the ability of seven selective muscarinic antagonists to inhibit carbachol-induced drinking in the rat. The muscarinic antagonists were given by intracerebroventricular (i.c.v.) injection 1 min before the i.c.v. injection of carbachol (1 p.gjrat). The M 2 antagonist, methoctramine, was inactive up to 80.3 nmoljrat. The M 3 antagonist, p-fluoro-hexahydro-sila-difenidol, elicited a modest (42%) but statistically significant inhibition of drinking only at 80 nmoljrat. On the other band, the selective M 1 antagonists, (R)-trihexyphenidyl, o-methoxy-sila-hexocyclium and pirenzepine, produced a marked and dose-dependent inhibition of carbachol-induced drinking, their 10 50 values being 0.51. 7.36 and 9.31 nmoljrat. Also the M 1 /M 3 antagonists, 4-diphenylacetoxy-Nmethylpiperidine methiodide and hexahydro-sila-difen.idol, were potent inhibitors of carbachol-induced drinking, their I 0 50 values (0.28 and 11.09 nmoljrat) being related to their pA 2 values for M 1 receptors in rabbi t vas deferens. These data suggest that carbachol-induced drinking may be mediated by activation of muscarinic M 1 receptors.
Introduction
The first indication of muscarinic receptor heterogeneity was derived from studies on agonist binding (Birdsall et al., 1980) . However, agonist binding curves are difficult to interpret in terms of receptor subtypes, owing to the complexity of agonist-receptor interaction, involving both different affinity states and coupling proteins. The discovery of antimuscarinic compounds which are selective for certain tissues or organs provided a more reliable approach to the subclassification of muscanmc receptors. On this basis, these receptors have been classified into at least three subtypes: M 1 (Hammer and Giachetti, 1982) , M 2 (M 20 , Mutschier et al., 1988 ; M 2 A, Eglen and Whiting, 1986) and M 3 (M 2 ß, Mutschier et al., 1988; M 28 , Eglen and Whiting, 1982) according to Doods et al. (1987) . Pirenzepine shows higher affinity for M 1 receptors than for the M 2 and M 3 types (Hammer and Giachetti, 1982) , methoctramine displays high selectivity for the M 2 type (Melchiorre et al., 1987; Melchiorre, 1988; in press; Michel and Whiting, 1988) , whereas hexahydrosila-difenidol and 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP) show higher affinity for M 3 and M 1 types than for M 2 receptors (Eitze and Figala, 1988; Mutschier et al., 1988; Barlow et al., 1976) . More recently, Lambrecht et al. (1988a, b, c) have developed the highly selective M 3 muscarinic antagonist, p-fluoro-hexahydro-sila-difenidol, as weil as the very potent and selective M 1 muscarinic antagonists, o-methoxysila-hexocyclium and (R)-trihexyphenidyl.
The centrat administration of acetylcholine agonists not only has several effects on the regulation of body fluids and of blood pressure in the rat: Stimulation of water intake, inhibition of salt appetite, release of vasopressin but in addition, produces a neuregenie hypertensive response (for review see Fitzsimons, 1979; Simpson, 1986) . The understanding of the functional relationships between these effects can only be understood if the receptor subtype involved is known. Selective pharmacological manipulations of these functions also can only be carried out with knowledge of the subtype of receptor involved in each of the above mentioned effects. On the basis of the available evidence that drinking induced by acetylcholine agonists is mediated by muscarinic receptors (Fitzsimons, 1979) . and taking advantage of the variety of selective muscarinic antagonists mentioned above. we designed the present study to investigate the subtype of muscarinic receptor involved in carbachol-induced drinking. An earlier investigation bad provided indications that M 2 receptors may not be involved (Massi et al., 1989) in the response.
Materials and methods

Anima/s
Male albino Wistar rats (Charles River, Calco Corno, Italy) averaging 250-275 g at the beginning of the experiments were housed individually in a temperature-controlled room on a 12: 12 Iightdark cycle. Food in pellets (MILL, Morini, Reggio Emilia, ltaly) and tap water were available ad libitum.
Drugs
The following drugs were used: carbachol (carbamoylcholine chloride) (Merck), (Ile 5 ]angiotensin II (Peninsula Lab. Inc. ); pirenzepine { 5,11-dihydro-11-[( 4-methyl-l-piperazinyl)-acetyl]-6H-pyrido [2,3-b] (1.4)benzodiazepin-6-one} dihydrochloride and (R)-trihexyphenidyl hydrochloride were kindly supplied by Dr. A. Giachetti and Dr. A.J. Aasen, respectively; methoctramine {N .N '-bis [6-[[(2-methoxybenzyl] 
and o-methoxy-sila-hexocyclium ( 4-{ [cyclohexylhydroxy(2-methoxyphenyl)silyl]methyl} -1, 1-dimethylpiperazinium methyl sulfate) were all synthesized in our laboratories.
Surgery and intracranial injections
All the animals were anesthetized (Equithesin, 3 mljkg body weight i.p.) and fitted by Stereotaxie surgery with a stainless-steel cannula ( o.d. 600 p.m) aimed at 1 mm above the lateral ventricle. The guide cannula was attached to the skull by means of jewelry screws and dental acrylic cement. The rats were aiJowed one week to recover from surgery before testing began.
The drugs to be tested were dissolved in sterile isotonic saline, with the exception of hexahydrosila-difenidol and p-fluoro-hexahydro-sila-difenidol that were dissolved in distilled water. being slightly soluble in isotonic saline. The drugs were given by intracerebroventricular (i.c.v.) injection through a stainless-steel injector (o.d. 300 p.m) temporarily inserted into the guide cannula and protruding 2 mm beyond the cannula tip. This technical expedient was adopted in order to reduce the possibility of back-flow of the solutions into the guide cannula. All the drugs were given in a constant volume of 1 p.l, except hexahydro-siladifenidol and p-fluoro-hexahydro-sila-difenidol that were given in a 2-1-ll volume.
Experimental pro<:edure
Effect of muscarinic antagonists on carbacholinduced drinking
Carbachol {lp.gjrat) was administered by i.c.v. injection to water-replete rats 1 min after the i.c.v. administration of a muscanmc antagonist or of vehicle (controls). After carbachol injection, the animals were retumed to their home cages where water and food were freely available. Water intake was recorded over a 2-h period of observation. For each antagonist, the experiment was carried out according to a 'within subjecf design, in which each rat received all the doses of antagonists as weil as the vehicle used for the antagonist itself. The rats were tested twice a week. Different groups of animals were used for the different antagonists.
4. Effect of muscarinic antagonists on angiotensin 11-induced drinking
(Ilc 5 ]Angiotensin II was given by i.c.v. injection to water-replete rats at the dose of 100 ngjrat. Again, muscarinic antagonists or simple vehicle were administered i.c.v. 1 min before (lle 5 )angiotensin II administration. Water intake was recorded for 60 min after the second i.c.v. injection. Only one dose of antagonist, the highest tested versus carbachol-induced drink.ing, was used. Each animal was also tested with the appropriate vehlcle.
5. Statistical analysis
The data are reported as means ± S.E.M. Statistical analysis of data for each compound tested was done by multifactorial analysis of variance (repeated measures) to check the overall significance of drug treatment. Planned pairwise comparisons were carried out by means of t-tests. Statistical significance was set at P < 0.05.
Results
1. Effect of muscarinic antagonists on carbacho/-induced drinking
Carbachol, given by pulse i.c. v. injection at a dose of 1 p.gjrat, induced copious drinking within 1 or 2 min following injection. Most of the dipsogenic response was expressed in the first 60-min period. However, additional drinkingwas also detected in several animals in the 2nd h of observation. The overall water intake in the 2-h period ranged between 8 and 12 ml of water ;rat in the different experimental groups. Figure 1 shows the dose-response relationships for the inhibitory effect of the muscarinic antagonists on carbachol-induced drinking. To compare the effects of these antagonists. water intake was expressed as percent of that of the controls and doses are reported in nmoljrat.
The potency (expressed as -log 10 50 ) of the seven antagonists tested to inhibit carbachol-induced drinking is reported in table 1. In the range of doses tested, none of the muscarinic antagonists evoked evident behavioural alterations that might have prevented the animal from drinking.
As seen in previous experiments (Massi et al., 1989) , the selective M 2 antagonist, methoctramine, produced a very slight inhibition of carbachol-induced drinking, in the range of doses from 3.3 to 80.3 nmoljrat (2.5-60 p.gjrat). The overall analysis of variance revealed the absence of a statistically significant drug effect, together with the absence of drug-time interaction. In the present study 60 p.g/rat was the highest dose of methoctramine tested, as we observed that administration of 100 p.gjrat plus carbachol 1 p.g pro- Melchiorre et al. (1987) , c Lambrecht et al. (1988a) . d Lambrecht et al. (1988c) . c Lambrecht et al. (1988b) , r Eltze (1988) , and 1 Eglen and Whiting (1986) . h Binding affinities (pKi values) at M 1 /M 2 /M 3 receptors, (R)-trihexyphenidyl: 9.0j7.7j8.1; 4-DAMP: 9.1/8.1/8.9 (Waelbroeck et al., 1988; Antagonist -log 10 50 (95% c.l.) duced heavy prostration~ followed by episodes of intense locomotor Stimulation often ending in rotations along the rat's longitudinal axis. The Mr selective antagonist, p-fluoro-hexahydro-sila-difenidol. evoked a slight and statistically not significant inhibition of carbachol-induced drinking at doses up to 40 nmoljrat (15.4 J.Lgfrat)-A significant drug effect was detected only in response to 80 nmoljrat (F(1,7) = 14.27; P < 0.01); pairwise comparisons showed that the inhibitory effect was significant throughout the 2-h period of observation. Even at this dose, however, the inhibition was less than 50%. Higher doses were not tested because of problems related to drug solubility. On the other band, the five other muscarinic antagonists tested evoked a marked suppression of carbachol-induced drinking, the mostpotent being 4-DAMP and (R)·trihexyphenidyl. The overall analyis of variance revealed a powerful effect of 4-DAMP in the range of doses tested (F(3,15) = 6.93; P < 0.005). Following the lowest dose of 0.06 nmoljrat (31 ngjrat) the intake of treated rats wa~. lower, but statistically indistinguishable from that of the controls_ The inhibitory effect. on the other band, was very pronounced and statistically significant at the dose of 0.276 and 1.10 nmoljrat. The time course of the drinking inhibition induced by 4-DAMP is shown in fig. 2 Finally. hexahydro-sila-difenidol proved to be essentially as potent as pirenzepine, its 10 50 being 11.09 nmol (95% c.l.: 3.15-39.03).
Effect of muscarinic antagonists on angiotensin 1/-induced drinking
To exclude the possibility that the muscarinic antagonists tested might have inhibited carbacholinduced drinking by producing a behavioural impairment, the same drugs were tested on angiotensin-induced drinking. For each drug we tested the highest dose used versus carbachol-induced drinking. Angiotensin I I evoked a very prompt dipsogenie response, within 15-60 s. Most of the drinking occurred in the first 15 min after i.c.v. injection and was usually complete in the first 30 min in most of the rats treated. The water intake 
Discussion
It is important to emphasize first that none of the musearlnie antagonists tested produced a significant inhibition of [Ile 5 ]angiotensin 11-induced drinking, even at the highest doses employed, versus carbachol-induced drinking (table 2) . This finding provides evidence that the inhibition of carbachol-induced drinking that we observed cannot be related to general behavioural impairment induced by the drugs. but is indeed the expression of a selective interaction with the cholinergic mechanism controlling drinking.
Concerning the characterization of the receptor subtype involved in carbachol-induced drinking, the present results suggest that M 1 receptors, rather than other subtypes of muscarinic receptors, apparently mediate the response. The possibility that M 2 receptor are involved is ruled out by the inactivity of the M 2 -selective muscarinic antagonist, methoctramine, in our test. This finding is in keeping with our previous results (Massi et al., 1989) , as weil as with the report of Schiavone et al. (1989) who used the M 2 antagonist. AF-DX 116. Moreover, the selective M 3 antagonist. p-fluorohexahydro-sila-difenidol, slightly inhibited drinking only at the very high dose of 80 nmoljrat, arguing against the involvement of an M 3 receptor. Finally. the observation that, as reported in table I. the five antagonists that inhibited carbachol-induced drinking effectively showed a good correlation between inhibitory potency in our test and affinity for the M 1 receptor in rabbit vas deferens is direct evidence in favour of the mediation of the effect by an M 1 receptor. In fact: (a) pirenzepine, hexahydro-sila-difenidol and omethoxy-sila-hexocyclium have pA 2 values for M 1 receptors clearly higher than those of methoctramine and of p-fluoro-hexahydro-sila-difenidol, which were clearly less potent to inhibit carbachol-induced drinking; (b) pirenzepine, hexahydro-sila-difenidol and o-methoxy-sila-hexocyclium, which have very similar pA 2 values (from 7.92 to 8.31), proved to be essentially equipotent in ouT test; (c) 4-DAMP and (R)-trihexyphenidyl, which have pA 2 values foT M 1 Teceptors higheT than those of the pTeviously mentioned antagonists, weTe also moTe potent in ouT test. lndeed, 4-DAMP pToved to be slightly more potent than (R)-tTihexyphenidyl although its affinity foT M 1 Teceptors is about one order of magnitude loweT in functional studies (table 1) . However, in binding experiments using NB-OK 1 cells, 4-DAMP and (R)-trihexyphenidyl competed equipotently with N-methylscopolamine at M 1 receptors (pKi = 9.1 and 9.0, respectively) (Waelbroeck et al., 1988; . The pA 2 values for M 2 and M 3 receptors of the seven antagonists tested aTe not related to theiT potency for inhibition of carbachol-induced drinking (table 1).
The conclusion from the present study is not consistent with that drawn from a previous one (Hagan et al., 1987) which suggested that M 2 andjor M 3 receptors would mediate cholinergic drinking in the rat. Indeed, the results in this report are not strictly comparable to ours, since these authors injected theiT substances diTectly into the lateral hypothalamus adjacent to the perifornical Tegion, while our drugs were injected into the ventricular space. PTobably, following i.c.v. injection, drugs Teach only to a slight extent the lateral hypothalamus while they can act at other sites such as the subfornical oTgan, which is very sensitive to the dipsogenie action of carbachol and, also is easily accessible fTom the ventTicular space. HoweveT, the different conclusion reached might have been a consequence of differences in pharmacological tools employed. In fact, Hagan et al. (1987) based their conclusions largely on the findings obtained with muscarinic agonists, while we used only antagonists. Our choice was related to the fact that putative M 1 agonists exhihit low efficacy and behave as partial agonists in a range of pharmacological and biochemical tests. Differences in efficacy due to variations in intrinsic activity or efficiency of receptor coupling, may give a false impression of Teceptor specificity. MoTeover, our study involved a greater variety of antagonists, including the most recent and selective M 2 and M 3 antagonists, methoctramine and p-fluoro-hexahydro-sila-difenidol, which gave clear-cut support to our hypothesis of the involvement of M 1 receptors in cholinergic-induced drinking.
